California Public Employees Retirement System Aprea Therapeutics, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$4.05 - $5.5 $60,345 - $81,950
-14,900 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$4.73 - $8.15 $6,437 - $11,092
-1,361 Reduced 8.37%
14,900 $76,000
Q4 2020

Feb 02, 2021
SELL
$4.92 - $30.67 $1,476 - $9,201
-300 Reduced 1.81%
16,261 $80,000
Q3 2020

Nov 05, 2020
BUY
$21.66 - $38.86 $12,996 - $23,316
600 Added 3.76%
16,561 $398,000
Q2 2020

Aug 12, 2020
BUY
$25.47 - $39.69 $406,526 - $633,492
15,961 New
15,961 $619,000

Others Institutions Holding APRE

# of Institutions
2
Shares Held
899
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email